Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05084196 · ClinicalTrials.gov registry record · Phase 3

Melatonin for Prevention of Kidney Injury

A Phase 3 study of Acute Kidney Injury and Adverse Drug Event, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
Phase 3
Development phase
300
Enrollment target
2
Study locations

NCT05084196 is a Phase 3 study of Acute Kidney Injury and Adverse Drug Event that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 300 participants, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05084196, a Phase 3 study of Acute Kidney Injury and Adverse Drug Event, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
Phase 3
Development phase
300 participants
Enrollment target
2
Study locations

Study Summary

This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.

Conditions Studied

Acute Kidney Injury Adverse Drug Event

Interventions

  • DRUG Melatonin
  • OTHER Placebo Capsule

Study Locations (2)

New Jersey

  • Robert Wood Johnson University Hospital - New Brunswick
  • Robert Wood Johnson University Hospital Somerset - Somerville

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-06-05
Est. Completion 2027-12-31
Phase Phase 3

Sponsor

Rutgers, The State University of New Jersey

413 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05084196

The ClinicalTrials.gov registry entry for NCT05084196 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,327-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (87% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 2 interventions - of which Melatonin is the first listed.

NCT05084196 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05084196 about?

NCT05084196 is a clinical study titled "Melatonin for Prevention of Kidney Injury". This study will evaluate the safety and effectiveness of melatonin for the prevention of antibiotic associated acute kidney injury in hospitalized patients.

What is the current status of trial NCT05084196?

This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2023-06-05. Estimated completion is 2027-12-31.

What conditions does trial NCT05084196 study?

This clinical trial studies the following conditions: Acute Kidney Injury, Adverse Drug Event.

What interventions are being tested in trial NCT05084196?

The interventions under investigation include: Melatonin (DRUG), Placebo Capsule (OTHER).

Who is sponsoring clinical trial NCT05084196?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05084196 being conducted?

This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Kidney Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Kidney Injury

All registered trials for this condition

Adverse Drug Event

All registered trials for this condition

New Jersey

All trials with a study site in New Jersey

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.